Tag: announcement

OTTAWA, June 26, 2025 (GLOBE NEWSWIRE) -- Colonnade BridgePort, a leading full-service real estate investment, development, and management company, has officially broken ground on RYSE, a new purpose-built multi-residential development located at 1950 Scott Street in Ottawa’s Westboro neighbourhood. Designed to meet the growing demand for high-quality rental housing in one of the city’s most sought-after communities, RYSE will offer a modern living experience that emphasizes connectivity, livability, and convenience.

SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- With the price of Bitcoin fluctuating around $100,000, many analysts predict that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to generate short-term profits in such conditions. As a result, 100x leverage futures trading has become the preferred tool for seasoned investors looking to maximize potential gains in this volatile market. BexBack Exchange is ramping up its efforts to offer traders unmatched promotional packages. The platform now features a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage on cryptocurrency trading, providing exceptional opportunities for investors.

Oeno Group recently celebrated its 10-year anniversary with an exclusive event for its clients.

Each party to offer Palladyne™AI’s embodied neuro-symbolic artificial intelligence Software bundled with Mobilicom’s OS3 cybersecurity solution

Hamilton, Bermuda, June 26, 2025 – Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announces today the pricing of $500 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2030 (the “Notes”), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company has also granted the initial purchasers of the Notes a 30-day option to purchase up to an additional $75 million aggregate principal amount of the Notes in connection with the offering. The offering is expected to close on June 30, 2025, subject to the satisfaction of certain customary closing conditions.

COPENHAGEN, Denmark, June 26, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of the first of two clinical trials designed to support approval and use of the MVA-BN^® mpox/smallpox vaccine in vulnerable populations: infants under 2 years of age and pregnant and breastfeeding women